Invitae to Announce First Quarter 2023 Financial Results on Tuesday, May 9, 2023

Rhea-AI Summary

Invitae (NYSE: NVTA) has announced the scheduled release of its first quarter 2023 financial results on May 9, 2023, at 4:30 PM Eastern/1:30 PM Pacific. The company will host a conference call and webcast to discuss the results and recent developments. Interested participants can register for the call via the provided link, after which they will receive access details. A live webcast will also be available, including a slide deck for additional insights. Invitae specializes in medical genetics, offering vital genetic information to enhance healthcare decisions for patients and healthcare providers. The company is committed to integrating comprehensive genetic information into mainstream medicine.

Positive

• Upcoming financial results announcement on May 9, 2023, showcasing transparency.
• Focus on improving healthcare through genetic information, aligning with market trends.

Negative

• None.

News Market Reaction

+4.03%

1 alert

+4.03% News Effect

On the day this news was published, NVTA gained 4.03%, reflecting a moderate positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

SAN FRANCISCO, April 26, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it will report its first quarter 2023 financial results on Tuesday, May 9, 2023, and will host a conference call and webcast that day at 4:30 p.m. Eastern / 1:30 p.m. Pacific to discuss its financial results and recent highlights.

To access the conference call, please register at the link below:
https://www.netroadshow.com/events/login?show=cd3e99e2&confId=49697

Upon registering, each participant will be provided with call details and access codes. 

The live webcast of the call and slide deck may be accessed here or by visiting the investors section of the company's website at ir.invitae.com. A replay of the webcast will be available shortly after the conclusion of the call and will be archived on the company's website.

About Invitae
Invitae (NYSE: NVTA) is a leading medical genetics company trusted by millions of patients and their providers to deliver timely genetic information simplified by digital technology. With accurate and actionable answers to strengthen medical decision-making, Invitae gives individuals and their families powerful, personalized insights that could improve and extend their lives. Invitae's genetics experts apply a rigorous approach to data and research, serving as the foundation of their mission to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people.

To learn more, visit invitae.com and follow for updates on Twitter, Instagram, Facebook and LinkedIn @Invitae.

Invitae Contacts:

Investor Relations
Hoki Luk
ir@invitae.com

Public Relations
Amy Hadsock
pr@invitae.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/invitae-to-announce-first-quarter-2023-financial-results-on-tuesday-may-9-2023-301807621.html

SOURCE Invitae Corporation

FAQ

When will Invitae announce its first quarter 2023 financial results?

Invitae will announce its first quarter 2023 financial results on May 9, 2023.

What time is Invitae's conference call for financial results?

The conference call will take place at 4:30 PM Eastern/1:30 PM Pacific on May 9, 2023.

How can I access Invitae's financial results webcast?

You can access Invitae's financial results webcast by registering through the provided link in their press release.

What is the focus of Invitae as a medical genetics company?

Invitae aims to bring comprehensive genetic information into mainstream medicine to improve healthcare outcomes.